| Stage | MDLN | % of rev | MCK | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $7.9B | 100.00% | $111B | 100.00% | MCK ×14.12 |
| Gross profit | $1.9B | 24.50% | $4.0B | 3.57% | MDLN +20.9pp |
| Operating income | $500M | 6.36% | $1.6B | 1.45% | MDLN +4.9pp |
| Pre-tax income | $386M | 4.91% | $1.6B | 1.41% | MDLN +3.5pp |
| Net income | $318M | 4.05% | $1.3B | 1.17% | MDLN +2.9pp |
| Stage | MDLN | MCK | Gap · A − B |
|---|---|---|---|
| Revenue | $7.9B100.00% | $111B100.00% | MCK ×14.12 |
| Gross profit | 24.50%$1.9B | 3.57%$4.0B | MDLN +20.9pp |
| Operating income | 6.36%$500M | 1.45%$1.6B | MDLN +4.9pp |
| Pre-tax income | 4.91%$386M | 1.41%$1.6B | MDLN +3.5pp |
| Net income | 4.05%$318M | 1.17%$1.3B | MDLN +2.9pp |
No shared counterparties.